Found: 19
Select item for more details and to access through your institution.
Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 11, p. 3139, doi. 10.1007/s12094-023-03286-3
- By:
- Publication type:
- Article
Hyperprogressive Disease: Main Features and Key Controversies.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 7, p. 3736, doi. 10.3390/ijms22073736
- By:
- Publication type:
- Article
PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 7, p. 1631, doi. 10.3390/ijms20071631
- By:
- Publication type:
- Article
Functional systemic CD4 immunity is required for clinical responses to PD‐L1/PD‐1 blockade therapy.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 7, p. N.PAG, doi. 10.15252/emmm.201910293
- By:
- Publication type:
- Article
LA EVALUACIÓN DE LA SATISFACCIÓN CON LOS CUIDADOS EN EL PACIENTE ONCOLÓGICO. EL SISTEMA DE MEDIDA DE LA EORTC.
- Published in:
- Psicooncologia, 2010, v. 7, n. 1, p. 35
- By:
- Publication type:
- Article
Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center.
- Published in:
- BMC Pharmacology & Toxicology, 2019, v. 20, n. 1, p. N.PAG, doi. 10.1186/s40360-019-0367-x
- By:
- Publication type:
- Article
Plasma fractalkine contributes to systemic myeloid diversity and PD‐L1/PD‐1 blockade in lung cancer.
- Published in:
- EMBO Reports, 2023, v. 24, n. 8, p. 1, doi. 10.15252/embr.202255884
- By:
- Publication type:
- Article
Corrigendum: PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00707
- By:
- Publication type:
- Article
The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00193
- By:
- Publication type:
- Article
Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 3846, doi. 10.3390/cancers14163846
- By:
- Publication type:
- Article
Identification of a Dexamethasone Mediated Radioprotection Mechanism Reveals New Therapeutic Vulnerabilities in Glioblastoma.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 361, doi. 10.3390/cancers13020361
- By:
- Publication type:
- Article
Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 344, doi. 10.3390/cancers12020344
- By:
- Publication type:
- Article
Systematic Review and Meta-Analysis of Randomized, Controlled Trials on Preoperative Physical Exercise Interventions in Patients with Non-Small-Cell Lung Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 7, p. 944, doi. 10.3390/cancers11070944
- By:
- Publication type:
- Article
Eribulin Mesylate in Breast Cancer.
- Published in:
- Women's Health (17455057), 2013, v. 9, n. 6, p. 517, doi. 10.2217/WHE.13.61
- By:
- Publication type:
- Article
Effects of a Multicomponent Exercise Program in Older Adults with Non-Small-Cell Lung Cancer during Adjuvant/Palliative Treatment: An Intervention Study.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 3, p. 862, doi. 10.3390/jcm9030862
- By:
- Publication type:
- Article
Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 2, p. 353, doi. 10.3390/jcm9020353
- By:
- Publication type:
- Article
Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 12, p. 2180, doi. 10.3390/jcm8122180
- By:
- Publication type:
- Article
CAR-T Cells for the Treatment of Lung Cancer.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 4, p. N.PAG, doi. 10.3390/life12040561
- By:
- Publication type:
- Article